TBN TuBerculosisNews

The most up to date evidence on the cost-effectiveness evidence on #TB infection testing in high-risk groups. #LTBI bmcpulmmed.biomedcentral.com/articles/10.11…

Today's the day! We are excited about the Global TB Summit 2022. Presentations start at 09:30 CET for EMEA and APAC and at 10:00 EDT for Americas. You can still register for the talks 👉 bit.ly/3TI00En #tbsummit2022

An effective vaccine is key to ending the TB pandemic. There are now six candidates in Phase III trials, enrolling ~75,000 people worldwide after 20+ years in the pipeline. Ten more are in Phases I/II. Our annual TB Vaccine Pipeline Report: treatmentactiongroup.org/wp-content/upl…

Our article, "Know your TB epidemic – is it time to add Mtb immunoreactivity back into global surveillance?" doi.org/jh3b just published in @PLOSGPH @aschwalbc @MphaDSP @kshanaube @petedodd24 @Rein_Houben @LizCorbett17 @petermacp 🧵1/8

@hannah_rickman @PLOSGPH @aschwalbc @MphaDSP @kshanaube @petedodd24 @Rein_Houben @LizCorbett17 @petermacp Fab article - congrats!

How can we protect children from #TB? Join QIAGEN webinar on pediatric TB with the experts Dr Ann M Loeffler and Dr. Danilo Buonsenso. linkedin.com/posts/riccardo…

Today is World #Tuberculosis Day: on this occasion, we talk to San Raffaele specialists on TB Daniela Maria Cirillo and Riccardo Alagna to learn about where we are in the fight against TB and what is needed to meet UN targets for 2030. Read the article: 👉 hubs.ly/H0JQF960

What are the operational challenges and opportunities of Integrated Research Platforms for phase II #tuberculosis trials? 🔬💊Tomorrow, Riccardo Alagna from @MyUniSR will present latest @imi_eupearl results at @EsMyco Congress. bit.ly/3cEDfhm @IMI_JU #clinicaltrials

Interested in learning about the potential for #biomarkers to improve TB research and therapy? Read our interview with Riccardo Alagna, a Research Fellow at @SanRaffaeleMI ➡️ bit.ly/20years-10 #EndTB

Good news for TB community! @QIAGEN has launched a novel portable device for TB testing in high-burden regions. This will help achieve global #endTB targets by increasing access to easy and reliable TB testing bloomberg.com/press-releases…

The November issue of IJTLD includes evaluation of a lateral-flow assay for TB, potential for a ban of heated tobacco products, high-dose isoniazid use in children affected by MDR-TB, and a review on the use of TB programmatic data – see ow.ly/Hjhi50GxL2Y #lunghealth #TB

Don't miss #LabCoP Extended ECHO Session on 14 October! Learn about screening for latent tuberculosis #TB infection in resource-limited settings and innovative solutions to meet EndTB goals. Register at conta.cc/3apL9tp @QIAGEN @RoscignoGiorgio

Signed up for the 2021 Global TB Clinical and Educational Summit yet? It's not too late! #TBSUMMIT2021

RD is not the main reason of pharmaceutical costs to the public.. 😡😡😡 @StopTbItalia @FerrareseMauri1 @PaolaCaste2 @paonicksot @AlibertiStefano @M_Raviglione @Amantum4 @RiccardiNiccolo @sikelos1986 @simone92v

#Tuberculosis is one of the leading infectious disease killers, yet the funding gap in TB R&D is estimated at more than 1 billion every year. This #WorldTBDay, read more from an interview with our TB specialists: bit.ly/3f9dSq3 #EndTB

There are 10 million new cases of TB and 1.4 million deaths each year. This #WorldTBDay, we are working with our partners to recognize the need for more research and improved options for the prevention, detection and treatment of #tuberculosis. eu-pearl.eu

The global roll-out of #Xpert has highlighted gaps that have limited its impact on the #TB care cascade. ASAP-GxNet represents the solution to improve the availability, accessibility, and quality of national GeneXpert networks. bit.ly/338WU3r

New tools in the #TB diagnostics pipeline are getting closer to meeting the target criteria set by @WHO & @FINDdx in terms of accuracy, time to results, affordability & point-of-care use. Read more about these exciting new tools in our Pipeline Report: treatmentactiongroup.org/resources/pipe…

Get the latest insights: Join Prof. Beate Kampmann to discuss childhood #tuberculosis at the 2020 TB Summit. Register now ⬇️ Event Oct 29-30 #stopTB #endTB #testandtreat

Register now!!!